Accelerate Diagnostics Inc

$ 21.78 <%= Resources.Global.txtDown %>
Updated 18/05/2018
Change % -1.69% Stock price decreasing
Change -0.375 Stock price decreasing
Volume 45,974
High $ 22.35
Low $ 21.50
Open $ 22.35
Prev close $ 22.15
# of shares 53.98M
Market cap 1,175.47M USD

Market closed
Accelerate Diagnostics Inc
Market is closed, opens at 14:30
Price development Latest 1 week 1 month 3 months 6 months 1 year
  21.78 9.4% Stock price increasing -11.1% Stock price decreasing -11.3% Stock price decreasing -11.8% Stock price decreasing -21.8% Stock price decreasing
Powered by TradingView

News about Accelerate Diagnostics Inc

  • English
  • Regulatory news

Company profile

Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques.

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
20 May 2018 16:35:09
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180515.2 - EUROWEB1 - 2018-05-20 17:35:09 - 2018-05-20 16:35:09 - 1000 - Website: OKAY